Omeros Corp. (OMER)
11.23
+0.49
(+4.56%)
USD |
NASDAQ |
Feb 06, 16:00
11.23
0.00 (0.00%)
After-Hours: 20:00
Omeros SG&A Expense (TTM) : 44.20M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Edgewise Therapeutics, Inc. | 36.80M |
| GeoVax Labs, Inc. | 6.16M |
| Vistagen Therapeutics, Inc. | 17.01M |
| Daré Bioscience, Inc. | 9.228M |
| REGENXBIO, Inc. | 80.53M |